Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Kahn Swick & Foti issued a shareholder-solicitation notice reminding HIMS investors of the November 2, 2026 lead plaintiff deadline in a securities class action (Velanki v. Hims & Hers Health, Inc.). The underlying class action stems from the FTC's July 29, 2026 lawsuit alleging Hims shared sensitive health data with ad platforms and used deceptive billing and cancellation practices; shares fell 14.73% to $25.00 that day.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.